Amidst the demands of providing care for patients with cancer, it can be challenging for oncologists and their care teams to keep up with the rapidly evolving field of genomics. Practical ways to apply the latest precision medicine discoveries is the focus of this year’s Individualizing Medicine Conference: Precision Cancer Care through Immunotherapy and Genomics, hosted by Mayo Clinic Center for Individualized Medicine on Sept. 20-21, at the Westin Kierland Resort & Spa, in Scottsdale, Arizona.
“We’re excited to launch the first Individualizing Medicine Conference focused on precision oncology. The conference brings together experts who have made discoveries that are already being used in the care of patients with many types of cancer. Our goal is to present and discuss case-based approaches to using genomics and new immunotherapies that attendees can bring back to their own patients,” says Alan Bryce, M.D., an oncologist and director, Genomic Oncology Clinic, at Mayo Clinic’s campus in Arizona.
Attendees will have the opportunity to learn from and interact with experts from Mayo Clinic and around the country who will discuss hot topics in precision oncology, including CAR T-cell therapy for hematologic cancers, tumor profiling with cell-free DNA testing, pharmacogenomics of cancer drugs and managing side effects from immunotherapies.
Presenters will also discuss care strategies for a wide range of cancers:
Preconference sessions will provide an in-depth look at the science driving many advances in cancer care:
Investigators are invited to submit an abstract for a poster session highlighting emerging research in precision medicine.
Tags: #CAR T-cell therapy, #CIMCon19, biliary cancer, breast cancer, Cancer, center for individualized medicine, Dr. Alan Bryce, education, familial cancer syndromes, hematologic cancers, immunotherapies, Individualizing Medicine Conference 2019, Lung Cancer, lymphoma, mayo clinic, Melanoma, Multiple Myeloma, myeloid cancers, oncology, pharmacogenomics, Precision Medicine, precision oncology, Prostate Cancer, Research, undiagnosed diseases